Skip to main content
Addgene

PB-U6-CNCB_sgEIF3D-4
(Plasmid #236766)

Print

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 236766 Standard format: Plasmid sent in bacteria as agar stab 1 $85
Add to Cart

Backbone

  • Vector backbone
    PB-U6-CNCB
  • Backbone manufacturer
    Synthetic
  • Backbone size w/o insert (bp) 8339
  • Total vector size (bp) 8342
  • Vector type
    Mammalian Expression ; PiggyBac
  • Selectable markers
    Blasticidin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    EIF3D sgRNA-4
  • gRNA/shRNA sequence
    CTGCTGCTAACGCGGTCCC
  • Species
    H. sapiens (human)
  • GenBank ID
    NM_003753.4
  • Entrez Gene
    EIF3D (a.k.a. EIF3S7, eIF3-p66, eIF3-zeta)
  • Promoter mouse U6 promoter

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site Esp3I (destroyed during cloning)
  • 3′ cloning site Esp3I (destroyed during cloning)
  • 5′ sequencing primer GAGGCTTAATGTGCGATAAAAGA
    • (Common Sequencing Primers)

Resource Information

Terms and Licenses

Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    PB-U6-CNCB_sgEIF3D-4 was a gift from Kazutoshi Takahashi (Addgene plasmid # 236766 ; http://n2t.net/addgene:236766 ; RRID:Addgene_236766)

  • For your References section:

    EIF3D safeguards the homeostasis of key signaling pathways in human primed pluripotency. Okubo C, Nakamura M, Sato M, Shichino Y, Mito M, Takashima Y, Iwasaki S, Takahashi K. Sci Adv. 2025 Apr 11;11(15):eadq5484. doi: 10.1126/sciadv.adq5484. Epub 2025 Apr 9. 10.1126/sciadv.adq5484 PubMed 40203091
Related items: